One tax director at a European pharmaceutical company talks to ITR about the strengths of advance pricing agreements (APAs) in an uncertain transfer pricing environment, where tax audits and disputes are increasingly common.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
Josh reports on transfer pricing, BEPS, tax disputes and other direct tax matters for ITR’s online and print audience. He covers a range of tax issues in these areas and how companies are dealing with them, as well as the influence of politics on tax developments.